# Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer

> **NCT00752115** · PHASE2,PHASE3 · COMPLETED · sponsor: **Hamamatsu University** · enrollment: 120 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** sildenafil
- **DRUG:** placebo
- **DRUG:** paclitaxel (taxol)
- **DRUG:** carboplatin (palaplatin)

## Key facts

- **NCT ID:** NCT00752115
- **Lead sponsor:** Hamamatsu University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2009-03
- **Final completion:** 2010-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2011-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00752115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00752115, "Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00752115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*